Clinical Trial Update: Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects [Phase 1]

View source ↗

Summary

The update describes the completion of a Phase 1 study evaluating the safety and metabolism of GSK376501 in overweight adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK376501

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED